Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
determinants of protection against CMV infection and disease and develop innovative vaccine concepts. You will use state of the art virus mutagenesis, real-time imaging of virus infection dynamics
-
available in the further tabs (e.g. “Application requirements”). Programme Description The Pre-Doc Award offers postdocs and those interested in a doctorate with a very good degree the opportunity to jointly
-
Description The International Max Planck Research School for Ultrafast Imaging and Structural Dynamics in Hamburg, Germany, offers a structured PhD program focusing on ultra-fast phenomena, X-ray
-
visual sensory processing. This knowledge is expected to contribute to a better understanding of sensory overload symptoms in everyday life in autism. The project builds on previous work by our group
-
institution. Biomolecular condensates have emerged as a new paradigm to understand biological functions in living cells. Dresden has pioneered research in the field of biomolecular condensates and developed
-
to coherent phase contrast imaging, particularly to ptychography at synchrotrons. Ptychography is a super resolution phase retrieval imaging technique capable of resolution down to single digit nanometres
-
to join our team, which is working in close collaboration on the development of our real AI-based automated shuttle (see image) with Autoware -stack for deployment on public roads, while researching
-
: nomination to the DAAD and standard application procedure at and final decision by the DAAD (online application with supporting documentation via the DAAD portal) Please send your application (via email as a
-
and performing laboratory (wind-wave facility) experiments, using state-of-the-art imaging techniques developing computational codes to process and understand large experimental datasets (e. g., image
-
, ideally with knowledge of Drosophila genetics and live imaging the applicant should be able to relocate for 6 months to our collaborator in Chile, where they will develop and optimize novel metabolite